Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Payables (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Payables for 11 consecutive years, with $2.3 million as the latest value for Q3 2022.

  • Quarterly Payables rose 7.36% to $2.3 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Sep 2022, up 7.36% year-over-year, with the annual reading at $1.1 million for FY2021, N/A changed from the prior year.
  • Payables hit $2.3 million in Q3 2022 for Kraig Biocraft Laboratories, up from $1.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $6.7 million in Q2 2021 to a low of $761999.0 in Q2 2019.
  • Historically, Payables has averaged $2.0 million across 4 years, with a median of $1.1 million in 2018.
  • Biggest five-year swings in Payables: soared 49.23% in 2018 and later plummeted 71.62% in 2022.
  • Year by year, Payables stood at $1.1 million in 2018, then fell by 29.67% to $784506.0 in 2019, then soared by 39.1% to $1.1 million in 2021, then skyrocketed by 110.85% to $2.3 million in 2022.
  • Business Quant data shows Payables for KBLB at $2.3 million in Q3 2022, $1.9 million in Q2 2022, and $2.2 million in Q1 2022.